Processa Pharmaceuticals Stock Price, News & Analysis (OTCMKTS:PCSA)

$3.36 0.00 (0.00 %)
(As of 12/11/2017 06:01 AM ET)
Previous Close$3.36
Today's RangeN/A
52-Week Range$0.98 - $5.11
VolumeN/A
Average Volume343 shs
Market Capitalization$829.61 million
P/E RatioN/A
Dividend YieldN/A
Beta1.32

About Processa Pharmaceuticals (OTCMKTS:PCSA)

Processa Pharmaceuticals, Inc., formerly Heatwurx, Inc., is a pharmaceutical company. The Company is focused on the development of drug products that are intended to improve the survival and/or quality of life for patients who have unmet medical need. The Company’s product portfolio includes 499. It is developing 499 for the treatment of Necrobiosis Lipoidica. It is also developing 499 for the treatment of effects related to head and neck cancer.

Receive PCSA News and Ratings via Email

Sign-up to receive the latest news and ratings for PCSA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorIndustrial Products
SymbolOTCMKTS:PCSA
CUSIPN/A
Phone+1-443-7763133

Debt

Debt-to-Equity RatioN/A
Current Ratio0.73%
Quick Ratio0.73%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value($0.21) per share
Price / Book-16.00

Profitability

Trailing EPS($0.04)
Net Income$-330,000.00
Net MarginsN/A
Return on EquityN/A
Return on Assets-1,994.61%

Miscellaneous

Employees1
Outstanding Shares246,910,000

Processa Pharmaceuticals (OTCMKTS:PCSA) Frequently Asked Questions

What is Processa Pharmaceuticals' stock symbol?

Processa Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PCSA."

When will Processa Pharmaceuticals make its next earnings announcement?

Processa Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, September, 24th 2018. View Earnings Estimates for Processa Pharmaceuticals.

Who are some of Processa Pharmaceuticals' key competitors?

Who are Processa Pharmaceuticals' key executives?

Processa Pharmaceuticals' management team includes the folowing people:

  • David Young Ph.D., Chairman of the Board, Chief Executive Officer, Interim Chief Financial Officer, Founder
  • Wendy Guy, Founder, Chief Administrative Officer
  • Patrick Lin, Founder, Chief Business & Strategy Officer, Internal Director
  • Sian Bigora, Chief Development Officer, Founder
  • Virgil D. Thompson, Director
  • Justin W. Yorke, Director

How do I buy Processa Pharmaceuticals stock?

Shares of Processa Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Processa Pharmaceuticals' stock price today?

One share of Processa Pharmaceuticals stock can currently be purchased for approximately $3.36.

How big of a company is Processa Pharmaceuticals?

Processa Pharmaceuticals has a market capitalization of $829.61 million. The company earns $-330,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis. Processa Pharmaceuticals employs 1 workers across the globe.

How can I contact Processa Pharmaceuticals?

Processa Pharmaceuticals' mailing address is 7380 Coca Cola Dr Ste 106, HANOVER, MD 21076-1789, United States. The company can be reached via phone at +1-443-7763133.


MarketBeat Community Rating for Processa Pharmaceuticals (PCSA)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  2 (Vote Underperform)
Total Votes:  5
MarketBeat's community ratings are surveys of what our community members think about Processa Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Processa Pharmaceuticals (OTCMKTS:PCSA) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for Processa Pharmaceuticals (OTCMKTS:PCSA)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Processa Pharmaceuticals (OTCMKTS:PCSA) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Processa Pharmaceuticals (OTCMKTS:PCSA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Processa Pharmaceuticals (OTCMKTS PCSA)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Processa Pharmaceuticals (OTCMKTS PCSA) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Processa Pharmaceuticals (OTCMKTS:PCSA) SEC Filings

DateFilerForm TypeView

Social Media

Financials

Financials are not available for this stock.

Chart

Processa Pharmaceuticals (OTCMKTS PCSA) Stock Chart for Monday, December, 11, 2017

Loading chart…

This page was last updated on 12/11/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.